UNH240927P577500
- 5.55
- -1.05-15.91%
UnitedHealth Newsroom
UnitedHealth Group Incorporated (UNH): Hedge Funds Are Bullish On This Health Insurance Stock Now
The Zacks Analyst Blog Highlights American Express, Coca-Cola and UnitedHealth
Novo Nordisk CEO Grilled by Senate Committee Over GLP-1 Prices
The "gunpowder smell" of the USA election is getting stronger! Reports of shots fired at and damage to Harris' campaign team, with no injuries.
At the same time, Trump is also focusing a lot of energy on economic policies, but some economists warn that Trump's tariffs and large-scale expulsion plan may lead to soaring prices.
Spotlight on UnitedHealth Group: Analyzing the Surge in Options Activity
US Pharmacies Commit to Expanded Coverage If Novo Lowers Weight-Loss Drug Prices: Bernie Sanders
PBMs Willing to Expand Coverage If Novo Nordisk Cuts Prices: Report
Is UnitedHealth Group Incorporated (UNH) the Best Stock to Invest in for Medium Term?
Wolfe Research Adjusts Price Target on UnitedHealth to $600 From $589
Jim Cramer Says UnitedHealth Group Inc. (UNH) Is An 'Unusual Rate Cut Winner'
Prominent Wall Street short sellers: Investors should focus on defensive stocks earnings and wait for clearer employment data.
Morgan Stanley maintains a neutral stance on defensive stocks related to cyclical sectors in the economy, waiting for 'clearer' employment data. The bank believes employment data is a key driving factor for the year-end stock market.
Is UnitedHealth Group Incorporated's (NYSE:UNH) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Harris accepted CNN's invitation for the second debate and called on Trump to "fight again."
①Harris posted on social media platform, saying:"I am glad to accept the second presidential debate on October 23rd, and I hope Trump can join." ②Currently, Trump's campaign team has not responded to Harris's invitation.
Express News | Optum Rx Responds to FTC Action
The Dow at 50,000. How It Could Happen -- and When. -- Barrons.com
Sector Update: Health Care Stocks Softer Friday Afternoon
FTC Sues PBMs of CVS, Cigna, UnitedHealth for Allegedly Inflating Insulin Prices
FTC 'Deeply Troubled' by Drug Manufacturers' Role in Raising Prices -- WSJ
FTC Sues Pharmacy Benefit Managers CVS Caremark, Express Scripts, OptumRx -- WSJ
PBMs' Strategy of Negotiating Rebates for Themselves Raised List Prices for Insulin, Was Unfair to Consumers, FTC Suit Says -- WSJ